Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2020 Aug 6;383(6):585-586.
doi: 10.1056/NEJMe2020388. Epub 2020 Jun 3.

Hydroxychloroquine for the Prevention of Covid-19 - Searching for Evidence

Myron S Cohen  1
Affiliations
Editorial

Hydroxychloroquine for the Prevention of Covid-19 - Searching for Evidence

Myron S Cohen. N Engl J Med. .
No abstract available

PubMed Disclaimer

Comment on

  • A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19.
    Boulware DR, Pullen MF, Bangdiwala AS, Pastick KA, Lofgren SM, Okafor EC, Skipper CP, Nascene AA, Nicol MR, Abassi M, Engen NW, Cheng MP, LaBar D, Lother SA, MacKenzie LJ, Drobot G, Marten N, Zarychanski R, Kelly LE, Schwartz IS, McDonald EG, Rajasingham R, Lee TC, Hullsiek KH. Boulware DR, et al. N Engl J Med. 2020 Aug 6;383(6):517-525. doi: 10.1056/NEJMoa2016638. Epub 2020 Jun 3. N Engl J Med. 2020. PMID: 32492293 Free PMC article. Clinical Trial.

References

    1. Cohen MS, Corey L. Combination prevention for COVID-19. Science 2020;368:551-551. - PubMed
    1. Rolain J-M, Colson P, Raoult D. Recycling of chloroquine and its hydroxyl analogue to face bacterial, fungal and viral infections in the 21st century. Int J Antimicrob Agents 2007;30:297-308. - PMC - PubMed
    1. Yao T-T, Qian J-D, Zhu W-Y, Wang Y, Wang G-Q. A systematic review of lopinavir therapy for SARS coronavirus and MERS coronavirus — a possible reference for coronavirus disease-19 treatment option. J Med Virol 2020;92:556-563. - PMC - PubMed
    1. Hernandez AV, Roman YM, Pasupuleti V, Barboza JJ, White CM. Hydroxychloroquine or chloroquine for treatment or prophylaxis of COVID-19: a living systematic review. Ann Intern Med 2020. May 27 (Epub ahead of print). - PubMed
    1. Boulware DR, Pullen MF, Bangdiwala AS, et al. A randomized trial of hydroxychloroquine as postexposure prophylaxis for Covid-19. N Engl J Med. DOI: 10.1056/NEJMoa2016638. - DOI - PMC - PubMed

Substances